Psykey, Inc. (OTCMKTS:CEOS) Sees Large Drop in Short Interest

Psykey, Inc. (OTCMKTS:CEOS) was the target of a large decline in short interest in November. As of November 15th, there was short interest totalling 2,400 shares, a decline of 79.8% from the October 31st total of 11,900 shares. Based on an average trading volume of 877,900 shares, the days-to-cover ratio is currently 0.0 days.

Psykey Stock Up 34.3 %

CEOS traded up $0.01 during trading on Wednesday, reaching $0.03. 985,402 shares of the stock were exchanged, compared to its average volume of 575,104. Psykey has a 1 year low of $0.01 and a 1 year high of $0.05. The business’s 50 day moving average price is $0.02 and its two-hundred day moving average price is $0.02.

Psykey Company Profile

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.